AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences
Authors: Salemi, M Vandamme, AM
Citation: M. Salemi et Am. Vandamme, Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences, J MOL EVOL, 54(1), 2002, pp. 62-70
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J
Authors: Fontaine, E Riva, C Peeters, M Schmit, JC Delaporte, E Van Laethem, K Van Vaerenbergh, K Snoeck, J Van Wijngaerden, E De Clercq, E Van Ranst, M Vandamme, AM
Citation: E. Fontaine et al., Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J, J ACQ IMM D, 28(3), 2001, pp. 254-258
Increasing prevalence of non-clade BHIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences
Authors: Balotta, C Facchi, G Violin, M Van Dooren, S Cozzi-Lepri, A Forbici, F Bertoli, A Riva, C Senese, D Caramello, P Carnevale, G Rizzardini, G Cremonini, L Monno, L Rezza, G Perno, CF Ippolito, G d'Arminio-Monforte, A Vandamme, AM Moroni, M
Citation: C. Balotta et al., Increasing prevalence of non-clade BHIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences, J ACQ IMM D, 27(5), 2001, pp. 499-505
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up
Authors: Vandamme, AM Houyez, F Banhegyi, D Clotet, B De Schrijver, G De Smet, KAL Hall, WW Harrigan, R Hellmann, N Hertogs, K Holtzer, C Larder, B Pillay, D Race, E Schmit, JC Schuurman, R Shulse, E Sonnerborg, A Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium
Authors: Van Vaerenbergh, K Debaisieux, L De Cabooter, N Declercq, C Desmet, K Fransen, K Maes, B Marissens, D Miller, K Muyldermans, G Sprecher, S Stuyver, L Vaira, D Verhofstede, C Zissis, G Van Ranst, M De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium, ANTIVIR TH, 6(1), 2001, pp. 63-70
Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution
Authors: Salemi, M Strimmer, K Hall, WW Duffy, M Delaporte, E Mboup, S Peeters, M Vandamme, AM
Citation: M. Salemi et al., Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution, FASEB J, 15(2), 2001, pp. 276-278
Dating the origin of the African human T-cell lymphotropic virus type-I (HTLV-I) subtypes
Authors: Van Dooren, S Salemi, M Vandamme, AM
Citation: S. Van Dooren et al., Dating the origin of the African human T-cell lymphotropic virus type-I (HTLV-I) subtypes, MOL BIOL EV, 18(4), 2001, pp. 661-671
Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype
Authors: Van Laethem, K Witvrouw, M Pannecouque, C Van Remoortel, B Schmit, JC Esnouf, R Kleim, JP Balzarini, J Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype, AIDS, 15(5), 2001, pp. 553-561
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
Authors: Miller, V Vandamme, AM Loveday, C Staszewski, S Lundgren, J Youle, M Ait-Khaled, M Boucher, C Brun-Vezinet, F Dedes, N Giaquinto, C Hertogs, K Houyez, F Perrin, L Pillay, D Schmit, JC Schuurman, R Lange, J Banhegyi, D Biondi, G Broekhuizen, A Bush-Donovan, C Camacho, R Carlier, H Clavel, F Clotet, B Clumeck, N Colebunders, R De Clerq, K De Jaegher, JJ De Schrijver, G De Smet, K Hall, W Harrigan, R Hatzakis, A Hellmann, N Hoetelmans, R Holtzer, C Katlama, C Larder, D Loriaux, E McCreedy, B Mulcahy, F Opravil, M Phillips, A Ruiz, N Shulse, E Sonnerborg, A Soriano, V Steel, H Vella, S Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors
Authors: Daelemans, D De Clercq, E Vandamme, AM
Citation: D. Daelemans et al., A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors, J VIROL MET, 96(2), 2001, pp. 183-188
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138
Authors: Pelemans, H Aertsen, A Van Laethem, K Vandamme, AM De Clercq, E Perez-Perez, MJ San-Felix, A Velazquez, S Camarasa, MJ Balzarini, J
Citation: H. Pelemans et al., Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138, VIROLOGY, 280(1), 2001, pp. 97-106
Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon
Authors: Van Dooren, S Salemi, M Pourrut, X Peeters, M Delaporte, E Van Ranst, M Vandamme, AM
Citation: S. Van Dooren et al., Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon, J VIROLOGY, 75(23), 2001, pp. 11939-11941
Re-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern
Authors: Paraskevis, D Magiorkinis, M Vandamme, AM Kostrikis, LG Hatzakis, A
Citation: D. Paraskevis et al., Re-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern, J GEN VIROL, 82, 2001, pp. 575-580
Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype
Authors: Paraskevis, D Magiorkinis, E Magiorkinis, G Anastassopoulou, C Lazanas, M Chrysos, G Vandamme, AM Hatzakis, A
Citation: D. Paraskevis et al., Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype, J GEN VIROL, 82, 2001, pp. 2509-2514
Clinical usefulness of human immunodeficiency virus drug resistance monitoring
Authors: Vandamme, AM De Clereq, E
Citation: Am. Vandamme et E. De Clereq, Clinical usefulness of human immunodeficiency virus drug resistance monitoring, ANTIRETROVIRAL THERAPY, 2001, pp. 243-277
Blinded, multicenter quality control study for the quantification of humanimmunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories
Authors: Muyldermans, G Debaisieux, L Fransen, K Marissens, D Miller, K Vaira, D Vandamme, AM Vandenbroucke, AT Verhofstede, C Schuurman, R Zissis, G Lauwers, S
Citation: G. Muyldermans et al., Blinded, multicenter quality control study for the quantification of humanimmunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories, CL MICRO IN, 6(4), 2000, pp. 213-217
Origins of HTLV-1 in South America
Authors: Vandamme, AM Hall, WW Lewis, MJ Goubau, P Salemi, M
Citation: Am. Vandamme et al., Origins of HTLV-1 in South America, NAT MED, 6(3), 2000, pp. 232-233
Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients
Authors: Van Laethem, K Schmit, JC Pelemans, H Balzarini, J Witvrouw, M Perez-Perez, MJ Camarasa, MJ Esnouf, RM Aquaro, S Cenci, A Perno, CF Hermans, P Sprecher, S Ruiz, L Clotet, B Van Wijngaerden, E Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy
Authors: Van Vaerenbergh, K Van Laethem, K Van Wijngaerden, E Schmit, JC Schneider, F Ruiz, L Clotet, B Verhofstede, C Van Wanzeele, F Muyldermans, G Simons, P Stuyver, L Hermans, P Evans, C De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Tempo and mode of human and simian T-lymphotropic Virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences
Authors: Salemi, M Desmyter, J Vandamme, AM
Citation: M. Salemi et al., Tempo and mode of human and simian T-lymphotropic Virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences, MOL BIOL EV, 17(3), 2000, pp. 374-386
Evolutionary strategies of human T-cell lymphotropic virus type II
Authors: Vandamme, AM Bertazzoni, U Salemi, M
Citation: Am. Vandamme et al., Evolutionary strategies of human T-cell lymphotropic virus type II, GENE, 261(1), 2000, pp. 171-180
Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir
Authors: Van Laethem, K Witvrouw, M Balzarini, J Schmit, JC Sprecher, S Hermans, P Leal, M Harrer, T Ruiz, L Clotet, B Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Simple algorithm derived from a geno-/phenotypic database to predict HIV-1protease inhibitor resistance
Authors: Schmidt, B Walter, H Moschik, B Paatz, C van Vaerenbergh, K Vandamme, AM Schmitt, M Harrer, T Uberla, K Korn, K
Citation: B. Schmidt et al., Simple algorithm derived from a geno-/phenotypic database to predict HIV-1protease inhibitor resistance, AIDS, 14(12), 2000, pp. 1731-1738
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
Authors: Van Vaerenbergh, K Van Laethem, K Albert, J Boucher, CAB Clotet, B Floridia, M Gerstoft, J Hejdeman, B Nielsen, C Pannecouque, C Perrin, L Pirillo, MF Ruiz, L Schmit, JC Schneider, F Schoolmeester, A Schuurman, R Stellbrink, HJ Stuyver, L Van Lunzen, J Van Remoortel, B Van Wijngaerden, E Vella, S Witvrouw, M Yerly, S De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II)
Authors: Lewis, MJ Novoa, P Ishak, R Ishak, M Salemi, M Vandamme, AM Kaplan, MH Hall, WW
Citation: Mj. Lewis et al., Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II), VIROLOGY, 271(1), 2000, pp. 142-154
Risultati: 1-25 | 26-40